Your leadership wants AI. Your compliance team wants governance.
Your team still does it manually.

The AI layer that only
a unified platform
makes possible

A secure, validated AI layer inside the CARA Platform for R&D, Regulatory, Safety and Quality teams. Keep data in-platform, automate & connect processes across the enterprise.

  • Documents never leave CARA
  • Role/permission-aware by default
  • Version control + audit trail on every output
Used by

THE PROBLEM WITH AI IN PHARMA

They don’t survive an inspection

Here’s what changes when AI is built into a unified platform
not bolted on top of fragmented data.

With CARA AI
Every output is source-linked and audit-ready.
Full traceability to controlled, validated content. Defensible in any inspection, by design.

One foundation. Cross-functional intelligence.
All functions share one data model. The AI draws from all of them in a single pass  natively.

GxP compliance is the architecture.
Not a feature added on top. The platform was built for regulated industries from the ground up.

Fragmented systems don’t just create manual work. They limit what AI can do. Every system you add creates costs you didn’t budget for.

Powered by AI

Built-in enterprise AI vs. bolt-ons and generic LLMs

The comparison isn’t about features.
It’s about what the architecture makes possible and what it makes impossible
.

CARA AI Section

What your team sees

One governed AI layer across Regulatory, Safety, Quality, and Clinical,
full traceability on every output.

Context-aware search

Surfaces regulatory precedents and clinical correlations that keyword search misses.

Automated classification

Every document tagged, categorised, and enriched automatically. Instant retrieval, every time.

Pre-tuned for compliance

Built-in prompts for regulatory workflows. Accurate from day one, customisable further.

Your LLM

Choose the model that fits. All processing stays in our secure framework. Your IP stays yours.

Data extraction

Pulls structured data from messy PDFs and clinical reports. Analysis-ready in seconds.

Source citations
Linked to the exact platform record
Full audit trail
Every action logged in the sidebar
Human review
Built into every workflow step

What becomes possible when all your data is on one platform. 

Across every function, across every task type

No separate system. No separate contract. No separate validation cycle.
Every function Regulatory, Safety, Quality, Clinical, delivers value from day one.
And the more of your operations run on CARA, the more your AI can see, connect, and do. 

CARA AI — What It Does
Regulatory

Module 2 summaries in hours, not days

70% faster authoring time
Deep dive — Regulatory
Safety

PBRER highlights without reading 60 pages

50–70% faster per reporting cycle
Deep dive — Safety
Quality

Audit reports distilled to what actually matters

50–80% faster documentation drafting
Deep dive — Quality
Clinical

100 pages of trial data — clear insights today

50–70% less writing effort
Deep dive — Clinical
Regulatory

Variation narratives and submission documents — not from scratch

70% faster authoring time
Deep dive — Regulatory
Safety

PBRER first drafts and RMP annexes from live data

50–70% faster per reporting cycle
Deep dive — Safety
Quality

SOPs and CAPAs — first drafts in minutes, not days

50–80% faster documentation drafting
Deep dive — Quality
Clinical

Patient narratives and CSR sections — consistently formatted

50–70% less writing effort
Deep dive — Clinical
Regulatory

Label changes checked against your PSMF, RMP, and submission history in one pass

1–2 days → minutes labeling comparison
Deep dive — Regulatory
Safety

Signal trends across your portfolio — spotted, not missed

Cross-portfolio signal detection
Deep dive — Safety
Quality

SOP version gaps identified before an audit does

Proactive gap detection
Deep dive — Quality
Clinical

Protocol deviations across sites — at a glance

Multi-site oversight in one view
Deep dive — Clinical
Regulatory

Health Authority query patterns — anticipated before they arrive

2–5 days → 20 min HA Q&A response
Deep dive — Regulatory
Safety

Benefit-risk signals surfaced before reporting deadlines

Earlier signal detection
Deep dive — Safety
Quality

Recurring deviations flagged before they compound

Proactive quality oversight
Deep dive — Quality
Clinical

Data lock risks visible weeks before they delay timelines

Earlier risk identification
Deep dive — Clinical
Regulatory

Submission dossiers in local formats — without starting over

Multi-market without rework
Deep dive — Regulatory
Safety

RMP annexes for multiple markets — technically consistent

Consistent across regions
Deep dive — Safety
Quality

SOPs across countries — technically accurate, no rework

No rework across regional variants
Deep dive — Quality
Clinical

ICFs in multiple languages — medically accurate across markets

Global trials without compliance risk
Deep dive — Clinical

Spend your time driving results, not drowning in documentation

Lower audit exposure with provable lineage

Faster cycles across teams; fewer handoffs

Lower cost per change/submission; fewer surprises

70–1,000+ hours saved per submission cycle
£4k–£60k saved per submission
99.9% uptime SLA

Regulatory

Module 2 summaries in hours, not days

70% faster
authoring time

SAFETY

PBRER highlights without reading 60 pages

50–70% faster
per reporting cycle

QUALITY

Audit reports distilled to what actually matters

50–80% faster
documentation drafting

CLINICAL

100 pages of trial data — clear insights today

50–70% less
writing effort

Regulatory

Variation narratives and submission documents — not from scratch

70% faster
authoring time

SAFETY

PBRER first drafts and RMP annexes from live data

50–70% faster
per reporting cycle

QUALITY

SOPs and CAPAs — first drafts in minutes, not days

50–80% faster
documentation drafting

CLINICAL

Patient narratives and CSR sections — consistently formatted

50–70% less
writing effort

Regulatory

Label changes checked against your PSMF, RMP, and submission history in one pass

1–2 days → minutes
labeling comparison

SAFETY

Signal trends across your portfolio — spotted, not missed

Cross-portfolio
signal detection

QUALITY

SOP version gaps identified before an audit does

Proactive
gap detection

CLINICAL

Protocol deviations across sites — at a glance

Multi-site
oversight in one view

Regulatory

Health Authority query patterns — anticipated before they arrive

2–5 days → 20 min
HA Q&A response

SAFETY

Benefit-risk signals surfaced before reporting deadlines

Earlier
signal detection

QUALITY

Recurring deviations flagged before they compound

Proactive
quality oversight

CLINICAL

Data lock risks visible weeks before they delay timelines

Earlier
risk identification

Regulatory

Submission dossiers in local formats — without starting over

Multi-market
without rework

SAFETY

RMP annexes for multiple markets — technically consistent

Consistent
across regions

QUALITY

SOPs across countries — technically accurate, no rework

No rework
across regional variants

CLINICAL

ICFs in multiple languages — medically accurate across markets

Global trials
without compliance risk

Spend your time driving results, not drowning in documentation

Lower audit exposure with provable lineage

Faster cycles across teams; fewer handoffs

Lower cost per change/submission; fewer surprises

70–1,000+ hours saved per submission cycle
£4k–£60k saved per submission
99.9% uptime SLA

Each function has a dedicated page with deeper use cases, implementation detail,
and outcome evidence.

HOW TO GET STARTED

Start where you need it.
Expand without friction.

Deploy CARA AI for one function today. When a second function is ready, they join the same platform no new vendor, no new validation, no new RFP process.

Potential Objection
A label comparison that also checks safety signals. A CAPA that surfaces related deviations across sites. A submission that draws from clinical, regulatory, and quality content simultaneously. These use cases only exist on a unified platform.

1

Start standalone — any function

Regulatory, Safety, Quality, or Clinical — each delivers immediate value on its own from day one.

AVAILABLE NOW

2

Connect when ready — same everything

Same platform. Same validation. Same vendor. A second function joins the foundation — it doesn’t integrate with it. No new RFP required.

NO FRICTION EXPANSION

3

Unlock the compound advantage

The more functions on the platform, the more your AI can do — with use cases that simply don’t exist on any other architecture.

THE COMPOUND ADVANTAGE

A label comparison that also checks safety signals. A CAPA that surfaces related deviations across sites. A submission that draws from clinical, regulatory, and quality content simultaneously. These use cases only exist on a unified platform.

Why Should You Trust Us?

Widely regarded by our customers for our responsiveness, we offer unprecedented care and attention to deliver a high-performing platform for all your needs. CARA now counts over 1,000,000 users across industries worldwide, including 8 of the 10 largest Life Science companies.

Used by

60%
of top pharma

1M+
Users

99.9%
Uptime SLA

Built on a platform that enterprise pharma already trusts

CARA AI runs on the same unified foundation already deployed across the world’s leading pharmaceutical companies. The platform that makes this AI possible has been proven in production, at scale, under inspection, across every major life sciences function.

25 +

Years in regulated life sciences

24/7

Expert Support

What Makes Us Different?

Purpose-Built AI for Life Sciences